$2.72
-0.0900 (-3.20%)
At Close: Aug 05, 2026
S420: The First Ever U.S. Cannabis Equity Index Future Contract
02:41pm, Wednesday, 23'rd Jun 2021
The Small Exchange celebrated its one-year anniversary with the launch of the first futures contract on marijuana stocks. Small Cannabis, listed under the S420 symbol, is based on an index that inclu
2 Top Canadian Marijuana Stocks To Watch Before July
03:41pm, Tuesday, 22'nd Jun 2021
Best Canadian Marijuana Stocks To Watch Next Month The post 2 Top Canadian Marijuana Stocks To Watch Before July appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding
Breaking Down a Wild Week in the World of Weed Stocks
01:41pm, Friday, 18'th Jun 2021
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continue
10 Marijuana Stocks to Buy for Their ‘Beyond the Flower' Plans
02:19pm, Thursday, 17'th Jun 2021
When it comes to marijuana stocks to buy, I've always favored companies that go beyond the flower into edibles and cannabis-infused drinks. The post 10 Marijuana Stocks to Buy for Their ‘Beyond th
As New York's recreational cannabis industry shapes up, companies are making deals to take full advantage of the emerging market. On Monday, Cronos Group, a Canadian cannabis company backed by Altria,
Top Canadian Marijuana Stocks In June? 2 To Watch This Week
03:00pm, Monday, 14'th Jun 2021
Are These Canadian Cannabis Stocks In A Loading Zone? The post Top Canadian Marijuana Stocks In June? 2 To Watch This Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of
7 Marijuana Stocks to Buy Now That Look Like Bargains
12:38pm, Monday, 14'th Jun 2021
These marijuana stocks are absolute bargains. And they're poised to take off as cannabis becomes legal across the U.S. The post 7 Marijuana Stocks to Buy Now That Look Like Bargains appeared first on
Cronos Group Shares Slightly Up After Announcing Purchase Of 10.5% Stake In PharmaCann For $110.4M
11:46am, Monday, 14'th Jun 2021
Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) is poised to acquire a stake in PharmaCann for approximately $110.4 million. Transaction Details: Under the terms of the agreement, a wholly-owned subsidiary
Canadian cannabis company Cronos purchases option to acquire 10.5% stake in PharmaCann for $110.4 million
07:45am, Monday, 14'th Jun 2021
Cronos Group Inc. said Monday it has purchased an option to acquire a 10.5% stake in U.S. cannabis company PharmaCann in a deal valued at $110.4 million. Under the terms of the deal, the option can be
Cronos Group Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company
07:30am, Monday, 14'th Jun 2021
Investment is Expected to Position Cronos Group to Benefit from Rapid Growth in the U.S. Cannabis Market
Smoked! How the Hottest Cannabis Stocks Fared This Week
09:55am, Friday, 11'th Jun 2021
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continue
Cannabis investors Discuss Strategies For 2021 In The Context Of Consolidation And Interstate Commerce
02:39pm, Wednesday, 09'th Jun 2021
2021 seems to be the year of cannabis, as its prospects and apparent societal acceptance have dramatically changed since the industry's early days. How are investors navigating this complex and ev
3 Pot Plays That Are Lighting Up With Momentum
01:08pm, Wednesday, 09'th Jun 2021
Momentum traders are moving into marijuana stocks and their charts look great. Here are top picks in the industry if you want to play along.
PSY: 14 Things to Know About the First Psychedelic Stocks ETF in the U.S.
12:56pm, Monday, 07'th Jun 2021
PSY (PSY) is getting extra attention on Monday as investors seek out new investments in the psychedelic medical market today. The post PSY: 14 Things to Know About the First Psychedelic Stocks ETF in
Cronos Group, Ginkgo Bioworks Modify Agreement To Speed Up Commercialization of Cultured Cannabinoids
01:50pm, Friday, 04'th Jun 2021
Cannabinoid company Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) is amending its previous partnership agreement with Ginkgo Bioworks, Inc., a company involved in cell programming. The amendment allo
Sign In
Buy CRON